Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting

scientific article

Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2014/509821
P932PMC publication ID4123521
P698PubMed publication ID25132703
P5875ResearchGate publication ID264043378

P50authorJeroen L PenningsQ58366852
Peter C J I SchielenQ88024799
Jacqueline E SiljeeQ96049913
P2093author name stringAnnemieke de Vries
Wendy Rodenburg
Sylwia Kuc
Sandra Imholz
P2860cites workADAM12: a novel first-trimester maternal serum marker for Down syndrome.Q34285873
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restrictionQ34647428
Antibody-based microarraysQ37391405
Impact of blood collection method on first-trimester dried blood free Beta hCG and PAPP-A.Q39027543
Quantitative performance of antibody array technology in a prenatal screening settingQ39692651
The stability of free-β human chorionic gonadotrophin and pregnancy-associated plasma protein-A in first trimester dried blood spotsQ39786440
Placental protein 13 as a first trimester screening marker for aneuploidyQ44807292
Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndromeQ46169856
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).Q47860634
Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies.Q51773716
Choosing near-linear parameters in the four-parameter logistic model for radioligand and related assays.Q52629105
First-trimester maternal serum alpha-fetoprotein as a marker for fetal chromosomal disorders. Dutch Working Party on Prenatal DiagnosisQ71683035
First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomesQ80473260
PAPP-A and free ss-hCG stability in first trimester serum using PerkinElmer AutoDELFIA and DELFIA Xpress systemsQ82258440
Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentationQ83438723
Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropinQ86174676
Placental pathology, first-trimester biomarkers and adverse pregnancy outcomesQ87113935
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P304page(s)509821
P577publication date2014-07-15
P1433published inDisease MarkersQ15756044
P1476titleComparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting
P478volume2014

Reverse relations

cites work (P2860)
Q38923334Dried blood spot measurement of pregnancy-associated plasma protein A (PAPP-A) and free β-subunit of human chorionic gonadotropin (β-hCG) from a low-resource setting
Q53697948Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women

Search more.